Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/08/2003US20030087329 Compound for use as diagnostic tool in protein analysis
05/08/2003US20030087328 Optical probe for use in detecting and measuring translational adjustments to proteins
05/08/2003US20030087323 Specific monoclonal antibody against terbinafine
05/08/2003US20030087319 Novel protein
05/08/2003US20030087315 Inhibitors of collagen assembly
05/08/2003US20030087313 Detection of G protein-coupled receptor; obtain cells, transfect with expression vectors, measure expression of reporter, detect adjusment in expression of reporter, altered expression indicates receptor with adjusted signaling
05/08/2003US20030087305 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/08/2003US20030087304 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/08/2003US20030087302 Detection of modulators of advanced glycation end product activity; obtain sample containing advanced glycation end product activity, incubate with peptide monitor adjustment in activity, adjustment in activity indicates modulator
05/08/2003US20030087299 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/08/2003US20030087287 Novel g-protein-coupled receptor protein and dna thereof
05/08/2003US20030087274 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/08/2003US20030087270 Nucleotide sequences coding polypeptide for use in the detection, classification, prevention and treatment of human cervical cancers
05/08/2003US20030087266 IGs as modifiers of the p53 pathway and methods of use
05/08/2003US20030087263 Screening activity of antitumor agents; obtain sample of peptide, incubate with antitumor agent, monitor binding of peptides, adjustment in binding of peptides indicates antitumor agent activity
05/08/2003US20030087255 Peptides which stimulate the immune response and tissue regeneration
05/08/2003US20030087253 Polynucleotide markers for ovarian cancer
05/08/2003US20030087252 Novel compositions and methods in cancer associated with altered expression of PRDM11
05/08/2003US20030087249 93870, a human G-protein coupled receptor and uses therefor
05/08/2003US20030087246 Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
05/08/2003US20030087243 Diagnosis, prognosis and treatment of cancer related to the Barx2 gene
05/08/2003US20030087227 Classification of microorganism; obtain sample of preferential microorganism, extract nucleotide sequences, incubate with probes, classify microorganisms
05/08/2003US20030087226 Human dna mismatch repair protein
05/08/2003US20030087225 Synthetic polynucleotide for use in the treatment of cell proliferative disorders
05/08/2003US20030086947 For diagnosis and prevention of ungulate diseases caused by treponeme spirochete bacteria
05/08/2003US20030086946 Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
05/08/2003US20030086945 Porcine reproductive and respiratory syndrome virus and methods of use
05/08/2003US20030086943 Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp41 glycoprotein ectodomain
05/08/2003US20030086942 Inhibition of nucleocytoplasmic transport by vesicular stomatitis virus M protein-like polypeptides
05/08/2003US20030086941 For diagnosing and therapy of gastrin-dependent tumor
05/08/2003US20030086940 For prophylaxis or therapy of rejection of xenotransplants are
05/08/2003US20030086938 Effecting presentation to the animal's immune system of an immunogenically effective amount of at least one analogue of autologous beta amyloid (A beta ) protein or autologous amyloid precursor
05/08/2003US20030086937 For therapy and prophylaxis of disease
05/08/2003US20030086936 For use in hematopoietic therapy; for arresting proliferation of leukemic cells
05/08/2003US20030086935 p53 vaccine
05/08/2003US20030086934 Basal cell markers in breast cancer and uses thereof
05/08/2003US20030086927 Administering to a host an agent which inhibits cyclin G1 protein, agent being administered in amount effective to inhibit cyclin G1 protein in tumor cells of host
05/08/2003US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
05/08/2003US20030086918 For specific cleavage and purification of poly amino acids that have low solubilities
05/08/2003US20030086911 Methods and compositions for the stimulation of human immunodeficiency virus-specific cytotoxic T lymphocytes employing autologous antigen-peripheral blood mononuclear cells
05/08/2003US20030086902 Searching for a peptide which binds to an antibody having an activity of neutralizing cytokine and which is capable of expressing a biological activity of cytokine from peptides not confirmed as having the biological activity of cytokine
05/08/2003US20030086893 Morphogenesis; therapy
05/08/2003US20030086872 SUT-2 and SUT-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
05/08/2003US20030086871 Exposing eukaryotic organisms to a single fungal pathogen in the presence of at least one candidate compound; identifying a compound that inhibits fungal pathogen in each of eukaryotic organisms
05/08/2003CA2756610A1 Methods for producing proteins having n-linked glycans comprising (sialyl-) lewis x or lacdinac structures
05/08/2003CA2466156A1 Ehrlichia disulfide bond formation proteins and uses thereof
05/08/2003CA2465792A1 Non-neurotoxic plasminogen activating factors for treating of stroke
05/08/2003CA2465714A1 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003CA2465639A1 Tumor antigen
05/08/2003CA2465371A1 Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration
05/08/2003CA2465367A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins
05/08/2003CA2465316A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003CA2465183A1 Compositions and methods for the therapy and diagnosis of lung cancer
05/08/2003CA2465123A1 Dermopharmaceutically and cosmetically active oligopeptides
05/08/2003CA2465037A1 Genetic vaccine against human immunodeficiency virus
05/08/2003CA2465001A1 Method for expanding hematopoietic stem cells
05/08/2003CA2464473A1 A rapid serological test for paratuberculosis using fluorescence polarization technology
05/08/2003CA2464199A1 A composition and method to alter lean body mass and bone properties in a subject
05/08/2003CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/08/2003CA2462652A1 New bacterium causing poultry disease and vaccine derived thereof
05/08/2003CA2458850A1 Fibrin nanoparticles and uses thereof
05/08/2003CA2441755A1 Human secreted proteins
05/07/2003EP1308729A2 Serological assay for neospora caninum
05/07/2003EP1308727A1 Method of screening substance for preventing or treating diseases in association with il-6 family cytokine receptor malfunction
05/07/2003EP1308517A1 Vectors for expressing multiple transgenes
05/07/2003EP1308515A2 Porcine factor VIII
05/07/2003EP1308514A2 ICAM-4 Materials and Methods
05/07/2003EP1308513A1 Use of polypeptide
05/07/2003EP1308511A1 Use of angiopoietin-like 1 and angiopoietin-like 2 nucleic acids and proteins for the treatment of blood-related disorders and defects in vasculature.
05/07/2003EP1308509A1 Novel physiologically active peptide and use thereof
05/07/2003EP1308462A1 Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
05/07/2003EP1308461A2 Antibodies to beta-amyloids or their derivatives and use thereof
05/07/2003EP1308460A2 Method and apparatus for preparing an acellular red blood cell substitute
05/07/2003EP1308459A2 Full-length cDNA sequences
05/07/2003EP1308458A1 New polynucleotides and polypeptides of the CX26 gene
05/07/2003EP1307748A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors
05/07/2003EP1307742A2 Recombinant phycobiliprotein and phycobiliprotein linker fusion proteins and uses therefore
05/07/2003EP1307609A2 Continuous electrolytic pickling method for metallic products using alternate current supplied cells
05/07/2003EP1307589A2 Method for detecting mutations in nucleotide sequences
05/07/2003EP1307582A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
05/07/2003EP1307572A2 Materials and methods for delivery and expression of heterologous dna in vertebrate cells
05/07/2003EP1307571A1 Gene expression from the internal ribosome entry site (ires) of rhopalosiphum padi virus (rhpv)
05/07/2003EP1307569A2 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use
05/07/2003EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
05/07/2003EP1307565A2 Vaccination against host cell-associated herpesviruses
05/07/2003EP1307564A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/07/2003EP1307563A1 Nucleotide sequences which code for the lysr2 gene
05/07/2003EP1307562A1 Nucleotide sequences which code for the lysr3 gene
05/07/2003EP1307561A2 Nucleic acids, with the aid of which plants having an altered metabolite content can be produced
05/07/2003EP1307560A2 Schizophrenia related gene and protein
05/07/2003EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line
05/07/2003EP1307558A2 Novel ebi-3-alt protein and nucleic acid molecules and uses therefor
05/07/2003EP1307557A2 Endothelial cell expression patterns
05/07/2003EP1307556A2 Compositions and methods for the therapy and diagnosis of colon cancer
05/07/2003EP1307555A2 18610, a human transient receptor and uses thereof
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307553A2 Mammalian dna binding membrane-associated protein-encoding gene and uses
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307551A2 Human ion channels
1 ... 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 ... 2916